| GTO ID | GTC0820 |
| Trial ID | ChiCTR1900025432 |
| Disease | Refractory Hematologic Cancer |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | CAR-T cell therapy for refractory/relapsed hematological malignancies in central nervous system |
| Year | 2019 |
| Country | China |
| Company sponsor | The First Affiliated Hospital, School of Medicine, Zhejiang University |
| Cohort 1 | |||||||
|
|||||||